Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-02-06T11:02:42.008Z Has data issue: false hasContentIssue false

Are children with protein-losing enteropathy after the Fontan operation at increased risk of cytomegalovirus enteropathy? A report of two cases

Published online by Cambridge University Press:  24 January 2020

Christoph Bauer*
Affiliation:
Department for Pediatric Cardiology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Linz, Austria
Gerald Tulzer
Affiliation:
Department for Pediatric Cardiology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Linz, Austria
*
Author for correspondence: C. Bauer, Department for Pediatric Cardiology, Kepler University Hospital GmbH, Johannes Kepler University Linz, 4020Linz, Austria. Tel: 00435768084/28422. E-mail: christoph.bauer@kepleruniklinikum.at
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Aetiology of protein-losing enteropathy in single-ventricle type CHD is multi-factorial.

Report:

We describe two Fontan patients with protein-losing enteropathy who presented with cytomegalovirus-associated colitis.

Discussion:

Fontan patients display risk factors for cytomegalovirus-induced gastroenteropathy that may affect lymph angiogenesis, disease development, and progression.

Conclusion:

Cytomegalovirus enteropathy may be common among Fontan patients who suffer from protein-losing enteropathy. Polymerase chain reaction is important for detection.

Type
Brief Report
Copyright
© Cambridge University Press 2020

Introduction

Protein-losing enteropathy in single-ventricle type CHD is a devastating complication after surgical palliation. Pathophysiologic processes are still poorly understood. It most likely has a multi-factorial aetiology and develops on the basis of an increased central venous pressure, genetic predisposing factors, alterations in haemodynamics, and inflammatory processes.Reference Rychik, Atz and Celermajer1,Reference Biko, Smith and Otero2

Several studies report on infections as potential trigger, but no association to cytomegalovirus has previously been described.Reference Rychik, Atz and Celermajer1

Report

Case 1

A boy with hypoplastic left heart syndrome who underwent an extracardiac fenestrated Fontan operation presented at the age of 6 years with six episodes of haematuria without significant proteinuria and concurrent hypoproteinaemia (3.6 g/dl). Renal disease was ruled out and haematuria resolved without treatment, but hypoproteinaemia and oedemas of the hands and eyelids remained. Random α1-Antitrypsin in stool turned out to be elevated and protein-losing enteropathy was diagnosed.

Workup included endoscopy of the gut, duodenum, and colon, and biopsies were taken of each segment. Besides a mild chronic inflammatory process of the colon and swelling of the mucous membrane, no macroscopic and histologic alteration could be found. Cytomegalovirus DNA was isolated in one specimen of the ascending colon, and cytomegalovirus colitis was diagnosed. The patient was treated with ganciclovir for 6 weeks and hypoproteinaemia resolved.

However, 1 year later, the patient presented again with hypoproteinaemia. Cytomegalovirus reactivation was excluded via serologic and urinary analysis and colonoscopy. Furthermore, the patient developed signs of plastic bronchitis 6 months later. Lymphatic imaging via the inguinal lymph nodes at that time demonstrated extensive lymphatic malformations that could not be treated with lymphatic intervention. Creation of a surgical anastomosis between the innominate vein and the right atrial appendage led to resolution of hypoproteinaemia.

Case 2

A boy with a history of single-ventricle type CHD and malposition of the great arteries who previously underwent a Norwood and Glenn operations at our facility was admitted for an extracardiac fenestrated Fontan completion at the age of 4 years. The post-operative course was complicated by profound cardiac insufficiency, acute renal impairment, and prolonged pleural effusions. In addition, the patient developed severe persistent diarrhoea with profound hypoproteinaemia (as low as 3.5 g/dl) that did not resolve during a 2-month course of budesonide. Finally, endoscopy of the gastrointestinal tract was performed and demonstrated mild inflammatory processes in the colon. A specimen of the ascending colon was positive for cytomegalovirus DNA (polymerase chain reaction).

Diarrhoea improved during a 4-week course of ganciclovir, but protein levels remained low. Three weeks after cessation of antiviral therapy, cytomegalovirus recurred (positive serum cytomegalovirus polymerase chain reaction) and another course of ganciclovir was initiated for 8 weeks. Again, protein levels did not improve and despite three consecutive negative serum and urinary samples for virus DNA, cytomegalovirus reactivated (positive urine cytomegalovirus polymerase chain reaction) just after discontinuing therapy. The following 10 months the patient received continuously antiviral therapy, and total protein levels increased temporary up to 6.2 g/dl. During follow-up, all subsequent serum, urine, and colonoscopy specimens remained negative for cytomegalovirus DNA. However, profound hypoproteinaemia recurred during treatment and the patient developed severe failing Fontan circulation. The patient was finally scheduled for heart transplantation but was rejected due to multiple end organ damage.

Discussion

We describe two patients with protein-losing enteropathy after the Fontan operation where during workup cytomegalovirus colitis was diagnosed. No such association has been reported before.

Cytomegalovirus infection in German children and adolescents is common (IgG seroprevalence: 21.4–33.5%).Reference Voigt, Schaffrath Rosario and Mankertz3 Involvement of the gastrointestinal tract is rare but even occurs in immunocompetent children and adults.Reference Megged and Schlesinger4,Reference Ko, Peck and Lee5

Fontan patients may be at increased risk for cytomegalovirus Enteropathy. In the majority of patients, cytomegalovirus colitis most likely results from viral reactivation rather than primarily infection.Reference Ko, Peck and Lee5,Reference Adler, Baggett and Mcvoy6 Steroid use and RBC transfusion within 1 month – treatments that are commonly seen in Fontan patients – were identified to be independent risk factors for the development of cytomegalovirus colitis in a limited case control study of 51 immunocompetent adult patients.Reference Ko, Peck and Lee5 Furthermore, cytokines like tumour necrosis factor-α and interferon-γ that have been suggested to play a central role in viral reactivation from latency have been reported to be elevated in Fontan patients.Reference Shimizu, Nagata and Fujii7,Reference Soderberg-Naucler8

Cytomegalovirus may play a pathophysiologic role in the development of protein-losing enteropathy in certain Fontan patients. The association of cytomegalovirus and protein-losing enteropathy has been well documented in immunocompromised children and adults as well as in several other specific diseases.Reference Ukarapol, Chartapisak and Lertprasertsuk9,Reference Cakir, Ersoz and Akbulut10 Pathophysiologic mechanisms and implication on disease development are not clear. However, human cytomegalovirus can infect lymphatic endothelial cells and promote angiogenesis and lymph angiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor.Reference Fiorentini, Luganini and Dell’Oste11 It hence may have the potential to affect lymphatics and promote protein-losing enteropathy. As both of our patients showed an unfavourable progression of disease despite treatment, there is concern that cytomegalovirus infection might be a risk factor for poor prognosis.

Cytomegalovirus-induced end organ disease in previously immunocompetent patients has been reported mostly in critically ill patients. A transient depression in immunity may predispose these patients to cytomegalovirus reactivation.Reference Siciliano, Castelli, Randi, Vieira and Strabelli12 It is not clear weather our observation reflects a causative relation between protein-losing enteropathy and cytomegalovirus infection or just an incidental finding in severely affected patients. Interestingly, we could not demonstrate a sustained improvement from protein-losing enteropathy after eradication in both patients. A possible explanation could be that promotion of inflammation is not the only pathophysiologic mechanism but changes in lymphatics occur too.

Conclusion

Cytomegalovirus enteropathy may be common among patients after the Fontan operation who suffer from protein-losing enteropathy. Routine endoscopic workup including polymerase chain reaction of specimens is important to identify affected patients. Further investigations are warranted to investigate extend and impact of cytomegalovirus infection on disease development, progression, and prognosis in this special population.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Conflict of interest

None.

Ethical standards

For this case report, no ethical clearance or informed consent was obtained because it summarises retrospective data that were exclusively collected for treatment and not for research.

References

Rychik, J, Atz, AM, Celermajer, DS, et al.Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation [Internet]. Juli 2019 [zitiert 30. Juli 2019]; Verfügbar unter: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000696Google Scholar
Biko, DM, Smith, CL, Otero, HJet al.Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics. Eur Radiol 2019; 29(10), 51905196. doi: 10.1007/s00330-019-06112-z.CrossRefGoogle ScholarPubMed
Voigt, S, Schaffrath Rosario, A, Mankertz, A.Cytomegalovirus seroprevalence among children and adolescents in Germany: Data from the German health interview and examination survey for children and adolescents (KiGGS), 2003–2006. Open Forum Infect Dis. 2016; 3(1), ofv193.CrossRefGoogle ScholarPubMed
Megged, O, Schlesinger, Y.Cytomegalovirus-associated protein-losing gastropathy in childhood. Eur J Pediatr 2008; 167(11), 12171220.CrossRefGoogle ScholarPubMed
Ko, J-H, Peck, KR, Lee, WJ, et al.Clinical presentation and risk factors for cytomegalovirus colitis in immunocompetent adult patients. Clin Infect Dis 2015; 60(6), e2026.CrossRefGoogle ScholarPubMed
Adler, SP, Baggett, J, Mcvoy, M.Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. The Lancet 1985; 326(8458), 743746.CrossRefGoogle Scholar
Shimizu, T, Nagata, S, Fujii, T, et al.Enhanced production of interferon-gamma as a possible cause of protein-losing enteropathy after modified Fontan operation. J Pediatr Gastroenterol Nutr 2003; 37(4), 504507.CrossRefGoogle ScholarPubMed
Soderberg-Naucler, C.Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 2006; 259(3), 219246.CrossRefGoogle ScholarPubMed
Ukarapol, N, Chartapisak, W, Lertprasertsuk, N, et al.Cytomegalovirus-associated manifestations involving the digestive tract in children with human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr 2002; 35(5), 669673.CrossRefGoogle ScholarPubMed
Cakir, M, Ersoz, S, Akbulut, UE.Disseminated cytomegalovirus infection and protein losing enteropathy as presenting feature of pediatric patient with Crohn’s disease. Pediatr Gastroenterol Hepatol Nutr 2015; 18(1), 6065.CrossRefGoogle ScholarPubMed
Fiorentini, S, Luganini, A, Dell’Oste, V, et al.Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. J Gen Virol 2011; 92(Pt 3), 650660.CrossRefGoogle ScholarPubMed
Siciliano, RF, Castelli, JB, Randi, BA, Vieira, RD, Strabelli, TM. Cytomegalovirus colitis in immunocompetent critically ill patients. Int J Infect Dis 2014; 20, 7173. doi: 10.1016/j.ijid.2013.11.008.CrossRefGoogle ScholarPubMed